Brief: Arbutus Biopharma And Vaccitech Announce Clinical Trial Collaboration Agreement To Evaluate Rnai Therapeutic, AB-729, In Combination With Immunotherapeutic, Vtp-300, In Subjects With Chronic Hepatitis B Virus Infection

Barinthus Biotherapeutics

06/07/2021 12:19

July 6 (Reuters) - Arbutus Biopharma Corp  ABUS.O :
    * ARBUTUS BIOPHARMA AND VACCITECH ANNOUNCE CLINICAL TRIAL
COLLABORATION AGREEMENT TO EVALUATE RNAI THERAPEUTIC, AB-729, IN
COMBINATION WITH IMMUNOTHERAPEUTIC, VTP-300, IN SUBJECTS WITH
CHRONIC HEPATITIS B VIRUS INFECTION

Source text for Eikon:  ID:nGNX2wkh5V 
Further company coverage:  ABUS.O 

 ((Reuters.Briefs@thomsonreuters.com;))